Estimated antiretroviral therapy coverage among people living with HIV in Guinea-Bissau
Guinea-Bissau: Estimated antiretroviral therapy coverage among people living with HIV was 82.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in Guinea-Bissau, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for estimated antiretroviral therapy coverage among people living with hiv in Guinea-Bissau is 82.0%, measured in 2025. That is the highest value across all 26 years on record.
The figure is up 7.9% on the previous year and up 215.4% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Guinea-Bissau peaked at 82.0% in 2025 and was at its lowest, 0.0%, in 2000.
That places Guinea-Bissau 44th out of 143 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in Guinea-Bissau, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 1.0% | — |
| 2007 | 2.0% | +100.0% |
| 2008 | 6.0% | +200.0% |
| 2009 | 8.0% | +33.3% |
| 2010 | 10.0% | +25.0% |
| 2011 | 14.0% | +40.0% |
| 2012 | 17.0% | +21.4% |
| 2013 | 18.0% | +5.9% |
| 2014 | 22.0% | +22.2% |
| 2015 | 26.0% | +18.2% |
| 2016 | 32.0% | +23.1% |
| 2017 | 33.0% | +3.1% |
| 2018 | 41.0% | +24.2% |
| 2019 | 46.0% | +12.2% |
| 2020 | 50.0% | +8.7% |
| 2021 | 56.0% | +12.0% |
| 2022 | 62.0% | +10.7% |
| 2023 | 62.0% | +0.0% |
| 2024 | 76.0% | +22.6% |
| 2025 | 82.0% | +7.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.7% | 0.0% | 8.0% | 10 |
| 2010s | 25.9% | 10.0% | 46.0% | 10 |
| 2020s | 64.7% | 50.0% | 82.0% | 6 |
Countries ranked near Guinea-Bissau
More health data for Guinea-Bissau
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7721 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,070 deaths per 1,000 people (2090)
- Number of infants who die before age 1 941 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.899 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0664 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.8987 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Guinea-Bissau?
- Estimated antiretroviral therapy coverage among people living with hiv in Guinea-Bissau was 82.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Guinea-Bissau?
- The highest recorded value was 82.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Guinea-Bissau?
- The lowest recorded value was 0.0% in 2000.
- How does Guinea-Bissau rank for estimated antiretroviral therapy coverage among people living with hiv?
- Guinea-Bissau ranks 44th out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Guinea-Bissau?
- Over the last ten years it is up 215.4%. The long-run trend across the full record is volatile.
- Where does this Guinea-Bissau data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).